UA97483C2 - Pyrimidine derivative as pi3k inhibitor and use thereof - Google Patents

Pyrimidine derivative as pi3k inhibitor and use thereof

Info

Publication number
UA97483C2
UA97483C2 UAA200902023A UAA200902023A UA97483C2 UA 97483 C2 UA97483 C2 UA 97483C2 UA A200902023 A UAA200902023 A UA A200902023A UA A200902023 A UAA200902023 A UA A200902023A UA 97483 C2 UA97483 C2 UA 97483C2
Authority
UA
Ukraine
Prior art keywords
pi3k inhibitor
pyrimidine derivative
formula
single bond
medical agent
Prior art date
Application number
UAA200902023A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Нобуо ШИММА
Хиросато ЭБИИКЕ
Джун Охвада
Хацуо КАВАДА
Кенджи Мориками
Мицуяки Накамура
Митюки Йошида
Нобуя Ишии
Масами ХАСЕГАВА
Шун Ямамото
Кохеи КОЯМА
Original Assignee
Чугай Сейяку Кабушики Кайша
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чугай Сейяку Кабушики Кайша filed Critical Чугай Сейяку Кабушики Кайша
Priority claimed from PCT/JP2007/065396 external-priority patent/WO2008018426A1/en
Publication of UA97483C2 publication Critical patent/UA97483C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a medical agent which is excellent in stability in living bodies and water solubility, while having excellent PI3K inhibitory activity. The medical agent is thus useful for prevention or treatment of cancers. Specifically disclosed is a compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof. (I) (In the formula, X represents a single bond or the like; Y represents a single bond or the like (provided that X and Y are not single bonds at the same time); Z represents a hydrogen atom or the like; m represents an integer of 1 or 2; and Rrepresents a cyclic substituent.)(I)
UAA200902023A 2006-08-08 2007-08-07 Pyrimidine derivative as pi3k inhibitor and use thereof UA97483C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006216108 2006-08-08
PCT/JP2007/065396 WO2008018426A1 (en) 2006-08-08 2007-08-07 Pyrimidine derivative as pi3k inhibitor and use thereof

Publications (1)

Publication Number Publication Date
UA97483C2 true UA97483C2 (en) 2012-02-27

Family

ID=40947307

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200902023A UA97483C2 (en) 2006-08-08 2007-08-07 Pyrimidine derivative as pi3k inhibitor and use thereof

Country Status (3)

Country Link
CN (1) CN101501035B (en)
UA (1) UA97483C2 (en)
ZA (1) ZA200900907B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013529212A (en) * 2010-05-19 2013-07-18 エクスカバリー ホールディング カンパニー，エルエルシー mTOR selective kinase inhibitor
CN104583215B (en) * 2012-08-30 2016-12-07 霍夫曼-拉罗奇有限公司 Diene also-and piperazine-[2,3-D] pyrimidine PI3K inhibitor compound and using method
GB201514760D0 (en) * 2015-08-19 2015-09-30 Karus Therapeutics Ltd Compounds and method of use
CN110563593A (en) * 2019-09-26 2019-12-13 新岸诺亚（北京）催化科技有限公司 Preparation method of N-methyl-4-bromoaniline
TW202128686A (en) * 2019-10-25 2021-08-01 大陸商江蘇恆瑞醫藥股份有限公司 A fused heteroaryl derivative, a preparation method and medical use thereof
CN113135942B (en) * 2020-01-17 2023-01-24 江苏恒瑞医药股份有限公司 Condensed pyrimidine derivative, preparation method and medical application thereof
CN111662185B (en) * 2020-06-18 2023-05-05 江苏富鼎化学有限公司 Synthesis method of N-methyl o-fluoroaniline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384937B2 (en) * 2002-11-06 2008-06-10 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
PL377821A1 (en) * 2002-11-21 2006-02-20 Chiron Corporation 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer

Also Published As

Publication number Publication date
CN101501035A (en) 2009-08-05
CN101501035B (en) 2013-01-23
ZA200900907B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
MY145385A (en) Pyrimidine derivative as p13k inhibitor and use thereof
TW200642683A (en) Heterocyclic compound
PT1940839E (en) Pyridopyrimidinone inhibitors of pi3kalpha
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
UA97483C2 (en) Pyrimidine derivative as pi3k inhibitor and use thereof
EA201001669A1 (en) SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281
EP2288260A4 (en) Triazolopyridine jak inhibitor compounds and methods
MX336271B (en) Triazolopyridine jak inhibitor compounds and methods.
TW200833675A (en) Nicotinamide derivatives
MX2009004441A (en) Indazole derivatives useful as l-cpt1 inhibitors.
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
MX2007013624A (en) Protein kinase inhibitors.
TNSN08070A1 (en) Benzoquinazoline derivatives and their use in treating bone disorders
TW200728307A (en) Novel spirochromanone derivatives
TN2010000293A1 (en) Thiazole derivatives used as pi 3 kinase inhibitors
JO3121B1 (en) 1-((5-heteroarylthiazol-2-yl)aminocarbonyl)pyrrolidine-2-carboxamide derivatives as phosphatidylinositol 3-kinase (pi3k) inhibitors useful in the treatment of proliferative diseases
MX338557B (en) Heterocyclic compound and use thereof.
MX2009006756A (en) 1-aminomethyl- l- phenyl- cyclohexane derivatives as ddp-iv inhibitors.
TW200745032A (en) Novel heterobicyclic derivatives
MX2010001020A (en) Organic compounds.
MX2009008756A (en) Macrocyclic compound.
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
MX2009008779A (en) Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination.
UA95972C2 (en) Aminopyridine derivatives having aurora a selective inhibitory action
PL1784402T3 (en) PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF